Does Rallies show KROS price targets?

Yes. Rallies tracks KROS analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.

Is KROS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for KROS. It does not provide personalized investment advice.

KROS (Keros Therapeutics, Inc. Common Stock) Stock Analysis - Analyst Ratings

Keros Therapeutics, Inc. Common Stock (KROS) is a publicly traded Healthcare sector company. As of November 5, 2026, KROS trades at $9.45 with a market cap of $214.73M and a P/E ratio of 5.17. KROS moved -13.25% today. Year to date, KROS is -47.57%; over the trailing twelve months it is -39.97%. Its 52-week range spans $9.12 to $22.55. Analyst consensus is buy with an average price target of $18.80. Rallies surfaces KROS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate KROS?

6 analysts cover KROS: 0 strong buy, 3 buy, 3 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $18.80.

KROS Key Metrics

Key financial metrics for KROS
Metric	Value
Price	$9.45
Market Cap	$214.73M
P/E Ratio

EPS	$2.34

Dividend Yield	0.00%

52-Week High	$22.55

52-Week Low	$9.12

Volume	216.88K

Avg Volume	0

Revenue (TTM)	$243.86M

Net Income	$87.01M

Gross Margin	0.00%

Common questions about KROS

What do analysts rate KROS?: 6 analysts cover KROS: 0 strong buy, 3 buy, 3 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $18.80.
Does Rallies show KROS price targets?: Yes. Rallies tracks KROS analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is KROS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for KROS. It does not provide personalized investment advice.

Keros Therapeutics

Analysts

Keros Therapeutics

Analysts

KROS Analyst Consensus

Common questions about KROS